Morbidity based on modality.

June 27, 2017. A population study published in JAMA adds to our knowledge that quality of life outcomes heavily depend on the treatment modality used to treat prostate cancer. You may recall the ProtecT trial back in 2016. This more recent report echoes many of those findings, namely: sexual dysfunction and incontinence come with surgery, urinary obstruction and frequency and more bowel problems come with radiation. So now we have even more data to arm our patients with informed decision-making. Counsel on.


Popular Posts